After-Hours Movers 09/22: (MOTR) (NKE) (FINL) (TQNT) Higher; (CAVM) (TDW) (HPQ) Lower
Up)
Motricity (NYSE: MOTR) 12% HIGHER; to explore strategic alternatives, receives $20 million in financing.
Cavium (Nasdaq: CAVM) 11% LOWER; now sees Q3 sales down 4-6 percent from Q2.
Nike Inc. (NYSE: NKE) 5% HIGHER; reported Q1 EPS of $1.36, $0.15 better than the analyst estimate of $1.21. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $5.75 billion. Nike XFX brand future orders up 13%.
Finish Line (NASDAQ: FINL) 4.6% HIGHER; reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $331.5 million versus the consensus estimate of $321.63 million. Comps up 11%.
TriQuint Semiconductor, Inc. (NASDAQ: TQNT) 3.7% HIGHER; now expects third quarter 2011 revenue to be between $210 and $215 million and third quarter non-GAAP net income per share to be between $0.09 and $0.11. In addition, non-GAAP gross margins for the third quarter are now expected to be 35% to 37% and non-GAAP operating expenses are expected to be about $60 million, including litigation expenses. The updated outlook compares to the Companyâs prior outlook of $225 to $235 million for revenue and $0.16 to $0.18 for non-GAAP net income per share. The consensus is currently EPS of $0.16 with $228.69 million in revenue.
Tidewater (NYSE: TDW) 2.4% LOWER; sees Q2 vessel sales below the $255-$260 million range the company provided on Aug. 4th.
HP (NYSE: HPQ) 0.6% LOWER; names Meg Whitman as President, CEO.
Immunomedics (Nasdaq: IMMU) INDICATED LOWER; shares down more than 11 percent from the close following news the FDA has put a partial hold on its Phase Ib/II trial on its clivatuzumab.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Cavium (Nasdaq: CAVM) 11% LOWER; now sees Q3 sales down 4-6 percent from Q2.
Nike Inc. (NYSE: NKE) 5% HIGHER; reported Q1 EPS of $1.36, $0.15 better than the analyst estimate of $1.21. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $5.75 billion. Nike XFX brand future orders up 13%.
Finish Line (NASDAQ: FINL) 4.6% HIGHER; reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $331.5 million versus the consensus estimate of $321.63 million. Comps up 11%.
TriQuint Semiconductor, Inc. (NASDAQ: TQNT) 3.7% HIGHER; now expects third quarter 2011 revenue to be between $210 and $215 million and third quarter non-GAAP net income per share to be between $0.09 and $0.11. In addition, non-GAAP gross margins for the third quarter are now expected to be 35% to 37% and non-GAAP operating expenses are expected to be about $60 million, including litigation expenses. The updated outlook compares to the Companyâs prior outlook of $225 to $235 million for revenue and $0.16 to $0.18 for non-GAAP net income per share. The consensus is currently EPS of $0.16 with $228.69 million in revenue.
Tidewater (NYSE: TDW) 2.4% LOWER; sees Q2 vessel sales below the $255-$260 million range the company provided on Aug. 4th.
HP (NYSE: HPQ) 0.6% LOWER; names Meg Whitman as President, CEO.
Immunomedics (Nasdaq: IMMU) INDICATED LOWER; shares down more than 11 percent from the close following news the FDA has put a partial hold on its Phase Ib/II trial on its clivatuzumab.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Top 10 News Items 5/21-5/25: Eurozone Fears Remain, But Stocks Charge Higher; Facebook Continues to Be Sold; HP Investors Cheer Q2 Results
- Notable Mergers and Acquisitions of the Day 05/25: (TLB) (MSFT)/(CMCSA) (BAC)
- Notable 52-Week Highs and Lows of the Day 05/24: (LCC) (PETM) (DUK) High; (NTAP) (RIMM) (CPRX) Low
Create E-mail Alert Related Categories
Special ReportsRelated Entities
After-Hours MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
